PROVIDER PROFILE · NPI 1902867294

Pierre Labrecque

DermatologySanta Maria, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$233K

Distinct drugs

Brand share

45.6%

Top prescribed drugs

Secukinumab23 claims

Clindamycin Phosphate20 claims

Apremilast13 claims

Ketoconazole12 claims

Spironolactone11 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Pierre Labrecque's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 39 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Pacific Point Laboratories, Inc. Clinical Laboratory · San Luis Obispo, CA	617	2,474
Bruce Ragsdale Pathology · San Luis Obispo, CA	229	579
Kurt Lundquist Pathology · San Luis Obispo, CA	109	197
BYERS, HUGH	103	269
Pacific Diagnostic Laboratories Clinical Laboratory · Santa Barbara, CA	58	144
COMMUNITY HEALTH CENTERS OF THE CENTRAL COAST INC	39	69
COMMUNITY HEALTH CENTERS OF THE CENTRAL COAST INC	32	66
SANTA BARBARA COUNTY AUDITOR	28	54
Unilab Corporation Clinical Laboratory · West Hills, CA	28	73
OURIEFF, BRUCE	27	99
LOMPOC VALLEY MEDICAL CENTER	25	50
NPI 1093733420	21	39

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history